NCT05491525View on ClinicalTrials.gov

A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

October 12, 2022

Primary Completion Date

January 31, 2027

Study Completion Date

September 30, 2027

Conditions
Neurogenic Detrusor Overactivity
Interventions
DRUG

Vibegron

Participants will be administered Vibegron orally, once daily (QD)

Trial Locations (6)

12208

RECRUITING

Albany Medical College, Albany

27710

RECRUITING

Duke University Medical Center, Durham

32207

RECRUITING

Nemours Childrens Health, Jacksonville, Jacksonville

67226

RECRUITING

Wichita Urology Group, Wichita

70118

RECRUITING

Childrens Hospital New Orleans, New Orleans

92868-4568

RECRUITING

Children's Hospital of Orange County, Orange

All Listed Sponsors
lead

Urovant Sciences GmbH

INDUSTRY